Altre lingue Lantheus Holdings, Inc.

Azioni

LNTH

US5165441032

Tempo differito Nasdaq Altri mercati azionari 21:58:28 23/05/2024			Variaz. 5gg	Var. 1 gen.
79,02 ^USD	-2,86%		-2,45%	+27,60%

15/05	Lantheus Holdings, Inc. annuncia le nomine dei dirigenti, con effetto dal 28 maggio 2024	CI
03/05	LANTHEUS HOLDINGS, INC. : Truist Securities ancora positivo	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Lantheus Holdings, Inc. Announces Management Appointments, Effective May 28, 2024	15/05
Lantheus Announces Executive Appointments to Accelerate Innovation	15/05
Lantheus Shares Rise After Reporting Higher Q1 Adjusted Earnings, Revenue; 2024 Guidance Raised	02/05
Lantheus to Seek M&A Opportunities	02/05
Lantheus Holdings, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024	02/05
Lantheus Holdings, Inc. Revises Revenue Guidance for the Full Fiscal Year 2024	02/05
Lantheus Holdings: Q1 Earnings Snapshot	02/05
(LNTH) LANTHEUS HOLDINGS Sees Q2 EPS Range $1.81 - $1.86	02/05
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q1 Revenue $370M	02/05
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q1 EPS $1.69	02/05
Lantheus Reports First Quarter 2024 Financial Results	02/05
Lantheus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time	18/04
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time	18/04
Lantheus Holdings Insider Sold Shares Worth $262,005, According to a Recent SEC Filing	07/03
Perspective Therapeutics, Inc. announced that it has received $87.409482 million in funding from Lantheus Holdings, Inc. and other investors	06/03
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024	05/03
Lantheus Holdings Says FDA Approves Expanded Use of Definity in Pediatric Patients	04/03
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients	04/03
Lantheus Holdings, Inc. Announces the FDA Approval of Definity (Perflutren Lipid Microsphere) for Pediatric Patients	04/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Lantheus Holdings, Inc.

Azioni

LNTH

US5165441032

Altre lingue

Filtri